DVA DaVita Inc. Common Stock
NYSE · Health Care · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 4, 2026
$178.69
· of 52w range
· above low
· to high
$101.0052w low
$247.4952w high
Market Cap (MRQ)
$11.43B
P/E (TTM)
14.7
EPS (TTM)
$12.15
Revenue (TTM)
$14.01B
your badges
52W Range
$101–$247
Analyst Rating
BUY
Price Target
$220
P/E
14.7
ROE
-149.4%
Net Profit Margin
6.0%
Your badge strip is empty — pin a metric anywhere on this page.
DVA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$178.69
Market Cap (MRQ)
$11.43B
P/E (TTM)
14.7
EPS (TTM)
$12.15
Revenue (TTM)
$14.01B
Div Yield
0.00%
ROE (TTM)
-149.4%
52W Range
$101–$247
DVA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Sept. 9, 2013 | 2-for-1 | Forward |
| June 16, 2004 | 3-for-2 | Forward |
| Oct. 21, 1997 | 5-for-3 | Forward |
About DaVita Inc. Common Stock Company overview from Wikipedia
DaVita Inc. (a shortened contraction of "dare vita, meaning "to give life" in the Italian language) is an American health care company, incorporated in Delaware and headquartered in Denver, that provides kidney dialysis services through a network of 2,657 outpatient centers in the United States. DaVita serves 200,500 patients (36% of the total of 557,000 patients in the U.S.), and has 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the 2026 Fortune 500.
## History
The company was founded in 1979 as Medical Ambulatory Care, Inc., a subsidiary of National Medical Enterprises, Inc. (now Tenet Healthcare).
In August 1994, 70% of the company was acquired by DLJ Merchant Banking Partners in a leveraged buyout for $75.5 million, including a $10.5 million investment by DLJ. The company then changed its name to Total Renal Care Holdings, Inc. In October 1995, the company became a public company via an initial public offering, raising $107 million. By December 1996, DLJ had made a 386% return on its $10.5 million investment.
On February 27, 1998, the company acquired Renal Treatment Centers for $1.3 billion in stock. The integration went poorly and in July 1999, the CEO and CFO resigned. After tripling in value between 1995 and 1998, by July 1999, the stock price was down 71% year-to-date. In October 1999, Kent J. Thiry, then 43 years old, was named CEO.
In 2000, the company sold its non-U.S. operations. In October 2000, the company was renamed DaVita Inc. In October 2005, the company acquired Gambro Healthcare. In 2012, DaVita acquired Healthcare Partners for $4.42 billion, which was renamed DaVita Medical Group. In June 2019, the division was sold to UnitedHealth Group for $4.3 billion. In 2014, DaVita acquired Colorado Springs Health Partners, with 600 employees and 110,000 patients. In March 2016, it acquired the Everett Clinic Medical Group, a 20-site physicians practice with 315,000 patients in the Seattle area, for $385 million. In May 2017, it acquired WellHealth Quality Care.
In October 2014, the company agreed to pay $350 million to settle claims that it provided illegal kickbacks to doctors. In June 2015, the company agreed to pay $450 million to settle allegations that it unnecessarily disposed of drugs and then billed the U.S. federal government for this waste. In June 2018, a jury awarded the families of 3 of the company's patients $383 million in wrongful death claims after the patients died from cardiac arrest after undergoing treatment at DaVita centers. In October 2018, it agreed to pay $270 million to settle allegations that it violated the False Claims Act by providing inaccurate information that caused Medicare Advantage Plans to receive inflated payments. James Swoben, a whistleblower, received $10 million.
In July 2021, a federal grand jury indicted DaVita and former CEO Kent Thiry on charges of labor market collusion alleging participation in conspiracies with Surgical Care Affiliates to suppress competition for the services of certain senior-level employees. The company and Thiry were acquitted by a jury in April 2022. In October 2021, the Federal Trade Commission imposed limits on the company engaging in more mergers in Utah because of its history of buying up competitors.
In 2024, the Federal Trade Commission began investigating Davita along with Fresenius Medical Care under allegations they use illegal tactics to push smaller companies out of the market. In May 2025, the benefits fund of the United Food and Commercial Workers Local 1776 filed a proposed class-action lawsuit against DaVita and Fresenius Medical Care, a rival dialysis provider, alleging that the two companies illegally conspired to inflate treatment costs.
Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗
sectorHealth Care
industryHealth Care
employees78,000
countryUS
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$13.64B2016-12-31 → 2025-12-31
EPS$9.842016-12-31 → 2025-12-31
Free Cash Flow$1.31B2016-12-31 → 2025-12-31
Net margin6.0%2018-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | DVA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | 14.75Y avg ≈13.0 | ≈13.0 | 23.4 | Undervalued | |
| P/S (TTM) | 0.85Y avg ≈0.8 | ≈0.8 | 1.8 | Undervalued | |
| P/B (MRQ) | -14.95Y avg ≈24.1 | ≈24.1 | · | · | |
| Price / FCF (TTM) | 7.15Y avg ≈7.2 | ≈7.2 | · | · | |
| Price / Cash Flow (TTM) | 5.25Y avg ≈4.9 | ≈4.9 | 11.3 | Undervalued | |
| Price / Tangible Book (MRQ) | -11.5 | · | · | · | |
| PEG Ratio | ≈1.6 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | DVA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin (TTM) | 15.2%5Y avg ≈14.3% | ≈14.3% | 9.2% | Top tier | |
| EBITDA Margin (TTM) | 20.2%5Y avg ≈20.1% | ≈20.1% | 12.7% | Top tier | |
| Pretax Margin (TTM) | 10.5%5Y avg ≈10.6% | ≈10.6% | 4.3% | Top tier | |
| Net Profit Margin (TTM) | 6.0%5Y avg ≈6.3% | ≈6.3% | 5.1% | Top tier | |
| ROA (TTM) | 4.8%5Y avg ≈4.6% | ≈4.6% | 3.7% | Top tier | |
| ROE (TTM) | -149.4%5Y avg ≈24.7% | ≈24.7% | 10.5% | Weak | |
| ROIC | -245.6%5Y avg ≈325.5% | ≈325.5% | 5.1% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | DVA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 1.55Y avg ≈1.3 | ≈1.3 | 1.5 | In line | |
| Quick Ratio (MRQ) | 1.15Y avg ≈1.0 | ≈1.0 | 1.0 | In line |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | DVA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 6.5%5Y avg ≈3.4% | ≈3.4% | · | · | |
| Revenue CAGR 3Y | 5.5%5Y avg ≈3.5% | ≈3.5% | · | · | |
| Revenue CAGR 5Y | 3.4% | · | · | · | |
| EPS YoY | -8.3%5Y avg ≈14.0% | ≈14.0% | · | · | |
| Net Income YoY | -20.2%5Y avg ≈4.5% | ≈4.5% | · | · | |
| EPS CAGR 3Y | 18.9%5Y avg ≈10.3% | ≈10.3% | · | · | |
| EPS CAGR 5Y | 9.3% | · | · | · | |
| Net Income CAGR 3Y | 10.0%5Y avg ≈1.6% | ≈1.6% | · | · | |
| Net Income CAGR 5Y | -0.70% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | DVA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.85Y avg ≈0.7 | ≈0.7 | 0.8 | In line | |
| Receivables Turnover | 6.05Y avg ≈6.0 | ≈6.0 | 10.6 | Weak | |
| Revenue / Employee | ≈$174.9K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Dividends Yield, payout ratio, dividend history, 5Y CAGR
Dividend Yield0.00%
Payout Ratio0.00%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
0.05%
Next Report
Oct 27, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 3, 2026 | $4.02 | $3.92 | 2.5% |
| March 31, 2026 | May 11, 2026 | $2.87 | $2.34 | 22.6% |
| Dec. 31, 2025 | $3.40 | $3.19 | 6.7% | |
| Sept. 30, 2025 | $2.04 | $3.25 | -37.3% | |
| June 30, 2025 | $2.95 | $2.83 | 4.2% | |
| March 31, 2025 | $2.00 | $1.97 | 1.7% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B | $11.55B | $11.39B | $11.40B | $10.88B | $10.71B | |
| SG&A Expense | $1.67B | $1.54B | $1.47B | $1.36B | $1.20B | $1.25B | $1.10B | $1.14B | $1.06B | $1.07B | |
| Operating Expenses | $11.60B | $10.73B | $10.54B | $10.27B | $9.82B | $9.86B | $9.75B | $9.88B | $9.06B | $8.68B | |
| Operating Income | $2.04B | $2.09B | $1.60B | $1.34B | $1.80B | $1.69B | $1.64B | $1.53B | $1.81B | $2.03B | |
| Other Non-op | $-103M | $-70M | $-19M | $-16M | $6M | $17M | $29M | $10M | $18M | $8M | |
| Pretax Income | $1.35B | $1.53B | $1.18B | $966M | $1.52B | $1.32B | $1.20B | $1.05B | $1.40B | $1.62B | |
| Income Tax | $293M | $280M | $220M | $198M | $307M | $314M | $280M | $258M | $324M | $432M | |
| Net Income | $747M | $936M | $692M | $560M | $978M | $774M | $811M | $159M | $664M | $880M | |
| EPS (Basic) | $10.06 | $11.02 | $7.62 | $6.03 | $9.30 | $6.46 | $5.29 | $0.93 | $3.52 | $4.36 | |
| EPS (Diluted) | $9.84 | $10.73 | $7.42 | $5.85 | $8.90 | $6.31 | $5.27 | $0.92 | $3.47 | $4.29 | |
| Shares (Basic) | 74,227,000 | 84,991,000 | 90,790,000 | 92,992,000 | 105,230,000 | 119,797,000 | 153,181,000 | 170,786,000 | 188,625,559 | 201,641,173 | |
| Shares (Diluted) | 75,885,000 | 87,274,000 | 93,182,000 | 95,834,000 | 109,948,000 | 122,623,000 | 153,812,000 | 172,365,000 | 191,348,533 | 204,904,656 | |
| EBITDA | $2.75B | $2.81B | $2.34B | $2.06B | $2.47B | $2.31B | $2.24B | $2.10B | $2.36B | $2.44B |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $676M | $795M | $380M | $244M | $462M | $325M | $1.10B | $323M | $508M | $675M | |
| Short-term Investments | $24M | $51M | $12M | $78M | $22M | $20M | $12M | $3M | $33M | $307M | |
| Receivables | $2.41B | $2.15B | $1.99B | $2.13B | $1.96B | $1.82B | $1.80B | $1.86B | $1.71B | $1.50B | |
| Inventory | $161M | $135M | $143M | $109M | $107M | $112M | $98M | $107M | $182M | $160M | |
| Prepaid Expense | $156M | $123M | $103M | $79M | $73M | $76M | $67M | $112M | $112M | $100M | |
| Other Current Assets | · | · | · | · | · | · | · | · | $112M | $100M | |
| Current Assets | $4.06B | $3.75B | $3.14B | $3.16B | $3.17B | $3.15B | $3.69B | $8.42B | $8.77B | $3.99B | |
| PP&E (Net) | $2.81B | $2.94B | $3.07B | $3.26B | $3.48B | $3.52B | $3.47B | $3.39B | $3.15B | $2.86B | |
| PP&E (Gross) | $9.42B | $9.20B | $8.83B | $8.52B | $8.24B | $8.00B | $7.44B | $6.92B | $6.25B | $5.56B | |
| Accum. Depreciation | $6.60B | $6.26B | $5.76B | $5.27B | $4.76B | $4.48B | $3.97B | $3.52B | $3.10B | $2.70B | |
| Goodwill | $7.55B | $7.38B | $7.11B | $7.08B | $7.05B | $6.92B | $6.79B | $6.84B | $6.61B | $6.02B | |
| Intangibles | $222M | $197M | $203M | $183M | $178M | $167M | $136M | $119M | $114M | $74M | |
| Other Non-current Assets | $247M | $262M | $271M | $316M | $137M | $80M | $116M | $72M | $47M | $34M | |
| Total Assets | $17.48B | $17.29B | $16.89B | $16.93B | $17.12B | $16.99B | $17.31B | $19.11B | $18.97B | $18.76B | |
| Accounts Payable | $696M | $547M | $515M | $480M | $402M | $434M | $404M | $463M | $509M | $457M | |
| Current Liabilities | $3.14B | $2.97B | $2.64B | $2.62B | $2.40B | $2.48B | $2.37B | $4.89B | $3.07B | $2.71B | |
| Capital Leases | $2.18B | $2.21B | $2.33B | $2.50B | $2.67B | $2.74B | $2.72B | $0 | · | · | |
| Deferred Tax | $757M | $665M | $726M | $783M | $831M | $810M | $578M | $563M | $486M | $531M | |
| Other Non-current Liabilities | $84M | $170M | $183M | $105M | $119M | $150M | $161M | $451M | $365M | $317M | |
| Total Liabilities | $16.32B | $15.19B | $14.15B | $14.70B | $14.75B | $14.09B | $13.81B | $14.08B | $13.08B | $12.93B | |
| Common Stock | $69.0K | $90.0K | $89.0K | $90.0K | $97.0K | $110.0K | $126.0K | $166.0K | $182.0K | $195.0K | |
| Retained Earnings | $-328M | $1.53B | $598M | $174M | $354M | $853M | $1.43B | $2.74B | $3.63B | $3.71B | |
| Treasury Stock | $200M | $1.39B | $0 | · | $0 | $0 | $0 | $0 | $0 | $0 | |
| AOCI | $-123M | $-311M | $-52M | $-69M | $-139M | $-66M | $-47M | $-35M | $13M | $-90M | |
| Stockholders' Equity | $-651M | $121M | $1.06B | $712M | $756M | $1.38B | $2.13B | $3.70B | $4.69B | $4.65B | |
| Liabilities + Equity | $17.48B | $17.29B | $16.89B | $16.93B | $17.12B | $16.99B | $17.31B | $19.11B | $18.97B | $18.76B | |
| Shares Outstanding | 68,549,000 | 90,369,000 | 88,824,000 | 90,411,000 | 97,289,000 | 109,933,000 | 125,843,000 | 166,387,000 | 182,462,000 | 194,554,000 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $708M | $716M | $736M | $721M | $668M | $617M | $601M | $575M | $544M | $495M | |
| Stock-based Comp | $140M | $103M | $112M | $95M | $102M | $91M | $68M | $73M | $35M | $38M | |
| Deferred Tax | $87M | $-58M | $-39M | $-76M | $60M | $241M | $42M | $274M | $-395M | $52M | |
| Amort. of Intangibles | $7M | $7M | $9M | $11M | $13M | $14M | $14M | $16M | $16M | $15M | |
| Other Non-cash | $205M | $324M | $558M | $263M | $122M | $256M | $551M | $691M | $1.06B | $447M | |
| Operating Cash Flow | $1.89B | $2.02B | $2.06B | $1.56B | $1.93B | $1.98B | $2.07B | $1.77B | $1.91B | $1.97B | |
| CapEx | $576M | $555M | $568M | $603M | $641M | $675M | $767M | $987M | $905M | $829M | |
| Investing Cash Flow | $-655M | $-771M | $-772M | $-630M | $-785M | $-825M | $3.00B | $-1.01B | $-1.36B | $-1.20B | |
| Debt Issued | $5.61B | $6.62B | $2.47B | $2.39B | $1.62B | $4.05B | $38.53B | $59.93B | $50.99B | $51.99B | |
| Net Debt Issued | $5.61B | $6.62B | $2.47B | $2.39B | $1.62B | $4.05B | $38.53B | $59.93B | $50.99B | $51.99B | |
| Stock Repurchased | $1.31B | $1.39B | $272M | $802M | $1.54B | $1.46B | $2.38B | $1.16B | $803M | $1.10B | |
| Net Stock Activity | $-1.31B | $-1.39B | $-272M | $-802M | $-1.54B | $-1.46B | $-2.38B | $-1.16B | $-803M | $-1.10B | |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | |
| Financing Cash Flow | $-1.37B | $-817M | $-1.17B | $-1.12B | $-1.08B | $-1.85B | $-4.70B | $-625M | $-766M | $-1.35B | |
| Net Change in Cash | $-122M | $415M | $126M | $-216M | $53M | $-707M | $369M | $137M | $-218M | $-577M | |
| Taxes Paid | $177M | $388M | $268M | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.31B | $1.47B | $1.49B | $961M | $1.29B | $1.30B | $1.31B | $785M | $1.00B | $1.13B |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 15.0% | 16.3% | 13.2% | 11.5% | 15.5% | 14.7% | 14.4% | 13.4% | · | · | |
| Net Margin | 5.5% | 7.3% | 5.7% | 4.8% | 8.4% | 6.7% | 7.1% | 1.4% | · | · | |
| Pretax Margin | 9.9% | 11.9% | 9.7% | 8.3% | 13.1% | 11.4% | 10.5% | 9.2% | · | · | |
| EBITDA Margin | 20.2% | 21.9% | 19.3% | 17.8% | 21.2% | 20.0% | 19.7% | 18.4% | · | · | |
| ROA | 4.3% | 5.5% | 4.1% | 3.3% | 5.7% | 4.5% | 4.5% | 0.84% | 3.5% | 4.7% | |
| ROE | -281.8% | 159.1% | 78.2% | 76.4% | 91.5% | 44.0% | 27.8% | 3.8% | 14.2% | 18.5% | |
| ROIC | -245.6% | 1410.5% | 123.4% | 149.4% | 189.8% | 93.3% | 59.0% | 31.1% | 29.7% | 28.3% |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.3 | 1.2 | 1.2 | 1.3 | 1.3 | 1.6 | 1.7 | 2.9 | 1.5 | |
| Quick Ratio | 1.0 | 1.0 | 0.9 | 0.9 | 1.0 | 0.9 | 1.2 | 0.4 | 0.7 | 1.2 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.6 | 0.6 | · | · | |
| Receivables Turnover | 6.0 | 6.2 | 5.9 | 5.7 | 6.1 | 6.4 | 6.2 | 6.4 | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-9.50 | $1.50 | $11.89 | $7.88 | $7.77 | $12.59 | $16.95 | $22.26 | $25.70 | $23.89 | |
| Revenue / Share | $179.79 | $146.84 | $130.28 | $121.15 | $105.68 | $94.20 | $74.04 | $66.17 | · | · | |
| Cash Flow / Share | $24.86 | $23.17 | $22.10 | $16.33 | $17.56 | $16.14 | $13.47 | $10.28 | $9.97 | $9.58 | |
| Cash / Share | $9.87 | $9.87 | $4.28 | $2.70 | $4.75 | $2.96 | $8.76 | $1.94 | $2.79 | $4.69 | |
| EPS (TTM) | $9.84 | $10.73 | $7.42 | $5.85 | $8.90 | $6.31 | $5.27 | $0.92 | $3.47 | $4.29 |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 6.5% | 5.6% | 4.6% | -0.08% | 0.59% | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.5% | 3.3% | 1.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 3.4% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -8.3% | 44.6% | 26.8% | -34.3% | 41.0% | · | · | · | · | · | |
| EPS CAGR 3Y | 18.9% | 6.4% | 5.5% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 9.3% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -20.2% | 35.4% | 23.4% | -42.7% | 26.5% | · | · | · | · | · | |
| Net Income CAGR 3Y | 10.0% | -1.5% | -3.7% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -0.70% | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B | $11.55B | $11.39B | $11.40B | $10.88B | $10.71B | |
| Net Income TTM | $747M | $936M | $692M | $560M | $978M | $774M | $811M | $159M | $664M | $880M | |
| Market Cap | $7.79B | $12.04B | $9.31B | $6.75B | $11.07B | $12.91B | $9.44B | $8.56B | $13.18B | $12.49B | |
| P/E | 11.5 | 13.9 | 14.1 | 12.8 | 12.8 | 18.6 | 14.2 | 55.9 | 20.8 | 15.0 | |
| P/S | 0.6 | 0.9 | 0.8 | 0.6 | 1.0 | 1.1 | 0.8 | 0.8 | 1.2 | 1.2 | |
| P/B | -12.0 | 99.4 | 8.8 | 9.5 | 14.6 | 9.3 | 4.4 | 2.3 | 2.8 | 2.7 | |
| P / Cash Flow | 4.1 | 6.0 | 4.5 | 4.3 | 5.7 | 6.5 | 4.6 | 4.8 | 6.9 | 6.4 | |
| P / FCF | 5.9 | 8.2 | 6.2 | 7.0 | 8.6 | 9.9 | 7.2 | 10.9 | 13.2 | 11.0 | |
| Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · | · | |
| Earnings Yield | 8.7% | 7.2% | 7.1% | 7.8% | 7.8% | 5.4% | 7.0% | 1.8% | 4.8% | 6.7% | |
| Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · | · | · | |
| Annual Payout | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.55B | $3.42B | $3.62B | $3.42B | $3.38B | $3.22B | $3.29B | $3.26B | $3.19B | $3.07B | $3.15B | $3.12B | $3.00B | $2.87B | $2.92B | $2.95B | |
| SG&A Expense | $423M | $422M | $472M | $414M | $413M | $374M | $414M | $394M | $368M | $362M | $401M | $377M | $364M | $332M | $380M | $365M | |
| Operating Expenses | $2.98B | $2.93B | $3.06B | $2.91B | $2.84B | $2.78B | $2.73B | $2.73B | $2.68B | $2.59B | $2.76B | $2.63B | $2.60B | $2.56B | $2.66B | $2.64B | |
| Operating Income | $579M | $482M | $561M | $506M | $538M | $439M | $565M | $535M | $506M | $484M | $390M | $496M | $405M | $312M | $256M | $312M | |
| Other Non-op | $8M | $4M | $-21M | $-41M | $-23M | $-18M | $-13M | $-17M | $-27M | $-13M | $-5M | $-20M | $1M | $4M | $-8M | $-5M | |
| Pretax Income | $435M | $341M | $383M | $309M | $369M | $286M | $414M | $373M | $371M | $372M | $289M | $378M | $295M | $215M | $147M | $207M | |
| Income Tax | $92M | $66M | $77M | $69M | $94M | $54M | $64M | $78M | $72M | $66M | $58M | $69M | $49M | $44M | $34M | $43M | |
| Net Income | $265M | $198M | $234M | $150M | $199M | $163M | $259M | $215M | $223M | $240M | $151M | $247M | $179M | $116M | $68M | $105M | |
| EPS (Basic) | $4.10 | $2.93 | $3.30 | $2.09 | $2.62 | $2.05 | $3.17 | $2.56 | $2.56 | $2.73 | $1.68 | $2.70 | $1.96 | $1.28 | $0.81 | $1.16 | |
| EPS (Diluted) | $4.02 | $2.87 | $3.22 | $2.04 | $2.58 | $2.00 | $3.08 | $2.50 | $2.50 | $2.65 | $1.64 | $2.62 | $1.91 | $1.25 | $0.81 | $1.13 | |
| Shares (Basic) | 64,781,000 | 67,390,000 | · | 72,075,000 | 75,943,000 | 79,368,000 | · | 83,721,000 | 86,899,000 | 87,775,000 | · | 91,322,000 | 90,984,000 | 90,497,000 | · | 91,160,000 | |
| Shares (Diluted) | 66,092,000 | 68,875,000 | · | 73,769,000 | 77,362,000 | 81,275,000 | · | 85,795,000 | 88,950,000 | 90,547,000 | · | 94,041,000 | 93,418,000 | 92,483,000 | · | 93,263,000 | |
| EBITDA | $579M | $660M | · | $506M | $538M | $615M | · | $535M | $506M | $671M | · | $496M | $405M | $490M | · | $312M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $669M | $644M | $676M | $706M | $708M | $439M | $795M | $1.07B | $416M | $345M | · | $449M | $327M | $317M | · | $368M | |
| Short-term Investments | $20M | $22M | $24M | $31M | $31M | $73M | $51M | $21M | $21M | $11M | · | $12M | $12M | $50M | · | $74M | |
| Receivables | $2.47B | $2.46B | $2.41B | $2.33B | $2.44B | $2.32B | $2.15B | $2.27B | $2.30B | $2.59B | · | $2.02B | $2.01B | $2.06B | · | $2.09B | |
| Inventory | $152M | $142M | $161M | $139M | $146M | $151M | $135M | $129M | $127M | $146M | · | $110M | $110M | $107M | · | $107M | |
| Prepaid Expense | $149M | $160M | $156M | $161M | $110M | $130M | $123M | $97M | $83M | $105M | · | $91M | $90M | $89M | · | $66M | |
| Current Assets | $4.19B | $4.06B | $4.06B | $4.11B | $4.09B | $3.64B | $3.75B | $4.04B | $3.47B | $3.68B | · | $3.14B | $3.00B | $3.04B | · | $3.20B | |
| PP&E (Net) | $2.75B | $2.75B | $2.81B | $2.85B | $2.85B | $2.90B | $2.94B | $2.94B | $2.98B | $3.03B | · | $3.10B | $3.16B | $3.22B | · | $3.24B | |
| PP&E (Gross) | · | · | $9.42B | · | · | · | $9.20B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $6.87B | · | $6.60B | · | · | · | $6.26B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $7.59B | $7.58B | $7.55B | $7.54B | $7.47B | $7.42B | $7.38B | $7.23B | $7.20B | $7.23B | $7.11B | $7.09B | $7.11B | $7.09B | $7.08B | $7.02B | |
| Intangibles | $229M | $229M | $222M | $220M | $212M | $205M | $197M | $198M | $191M | $201M | · | $185M | $192M | $187M | · | $180M | |
| Other Non-current Assets | $299M | $267M | $247M | $204M | $193M | $239M | $262M | $219M | $240M | $262M | · | $302M | $314M | $291M | · | $308M | |
| Total Assets | $17.71B | $17.50B | $17.48B | $17.56B | $17.49B | $17.12B | $17.29B | $17.50B | $17.03B | $17.43B | · | $16.93B | $16.96B | $16.73B | · | $16.96B | |
| Accounts Payable | $716M | $691M | $696M | $656M | $594M | $596M | $547M | $488M | $494M | $490M | · | $435M | $428M | $448M | · | $417M | |
| Current Liabilities | $2.86B | $2.87B | $3.14B | $3.02B | $2.93B | $2.91B | $2.97B | $2.94B | $2.99B | $2.58B | · | $2.54B | $2.40B | $2.57B | · | $2.54B | |
| Capital Leases | $2.19B | $2.16B | $2.18B | $2.10B | $2.12B | $2.16B | $2.21B | $2.24B | $2.28B | $2.31B | · | $2.34B | $2.38B | $2.46B | · | $2.56B | |
| Deferred Tax | $826M | $819M | $757M | $742M | $646M | $665M | $665M | $660M | $694M | $720M | · | $754M | $760M | $771M | · | $819M | |
| Other Non-current Liabilities | $99M | $89M | $84M | $172M | $156M | $167M | $170M | $183M | $179M | $180M | · | $185M | $183M | $100M | · | $107M | |
| Total Liabilities | $16.63B | $16.45B | $16.32B | $16.22B | $15.94B | $15.46B | $15.19B | $15.28B | $14.60B | $14.79B | · | $14.10B | $14.33B | $14.31B | · | $14.89B | |
| Common Stock | $69.0K | $69.0K | $69.0K | $91.0K | $91.0K | $91.0K | $90.0K | $90.0K | $90.0K | $90.0K | · | $91.0K | $91.0K | $91.0K | · | $98.0K | |
| Retained Earnings | $81M | $-179M | $-328M | $2.05B | $1.90B | $1.70B | $1.53B | $1.28B | $1.06B | $838M | · | $715M | $469M | $290M | · | $847M | |
| Treasury Stock | $788M | $489M | $200M | $2.90B | $2.49B | $2.04B | $1.39B | $1.02B | $616M | $240M | · | · | · | · | · | $788M | |
| AOCI | $-59M | $-87M | $-123M | $-116M | $-138M | $-227M | $-311M | $-162M | $-195M | $-100M | · | $-69M | $-7M | $-55M | · | $-136M | |
| Stockholders' Equity | $-765M | $-755M | $-651M | $-572M | $-370M | $-267M | $121M | $387M | $633M | $926M | · | $1.20B | $1.02B | $825M | · | $533M | |
| Liabilities + Equity | $17.71B | $17.50B | $17.48B | $17.56B | $17.49B | $17.12B | $17.29B | $17.50B | $17.03B | $17.43B | · | $16.93B | $16.96B | $16.73B | · | $16.96B | |
| Shares Outstanding | 63,955,000 | 69,190,000 | 68,549,000 | 70,977,000 | 74,217,000 | 77,277,000 | 80,536,000 | 82,624,000 | 85,081,000 | 89,822,000 | 88,824,000 | 91,348,000 | 91,271,000 | 90,650,000 | 90,411,000 | 90,104,000 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $168M | $178M | $180M | $177M | $175M | $176M | $167M | $187M | $176M | $187M | $186M | $188M | $184M | $178M | $183M | $194M | |
| Stock-based Comp | $26M | $28M | $38M | $39M | $33M | $30M | $27M | $27M | $24M | $25M | $30M | $27M | $30M | $25M | $18M | $28M | |
| Deferred Tax | $-1M | $55M | $18M | $79M | $-14M | $4M | $-4M | $-25M | $-25M | $-3M | $-22M | $-2M | $-13M | $-4M | $-40M | $-45M | |
| Other Non-cash | · | $-137M | · | · | · | $-193M | · | · | · | $-583M | · | · | · | $147M | · | · | |
| Operating Cash Flow | $490M | $321M | $541M | $842M | $324M | $180M | $548M | $810M | $799M | $-135M | $485M | $661M | $450M | $463M | $344M | $711M | |
| CapEx | $170M | $102M | $145M | $166M | $121M | $143M | $171M | $139M | $125M | $121M | $159M | $137M | $124M | $148M | $194M | $144M | |
| Investing Cash Flow | $-194M | $-139M | $-163M | $-263M | $-67M | $-162M | $-248M | $-146M | $-162M | $-215M | $-168M | $-140M | $-347M | $-117M | $-213M | $-154M | |
| Debt Issued | $1.51B | $1.26B | $940M | $482M | $3.56B | $633M | $676.0K | $3.35B | $1.99B | $1.29B | $6.0K | $331M | $1.53B | $612M | $687M | $523M | |
| Net Debt Issued | · | $1.26B | · | · | · | $633M | · | · | · | $1.29B | · | · | · | $612M | · | · | |
| Stock Repurchased | $181M | $196M | $274M | $240M | $284M | $510M | $365M | $408M | $362M | $251M | $272M | $0 | $0 | $0 | $0 | $185M | |
| Net Stock Activity | · | $-196M | · | · | · | $-510M | · | · | · | $-251M | · | · | · | $0 | · | · | |
| Financing Cash Flow | $-270M | $-213M | $-415M | $-582M | $4M | $-383M | $-565M | $-8M | $-563M | $319M | $-403M | $-395M | $-97M | $-276M | $-231M | $-445M | |
| Net Change in Cash | $25M | $-31M | $-38M | $-2M | $272M | $-355M | $-279M | $655M | $72M | $-34M | $-80M | $123M | $11M | $72M | $-123M | $106M | |
| Free Cash Flow | · | $219M | · | · | · | $37M | · | · | · | $-256M | · | · | · | $315M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 16.3% | 14.1% | · | 14.8% | 15.9% | 13.6% | · | 16.4% | 15.9% | 15.8% | · | 15.9% | 13.5% | 10.8% | · | 10.6% | |
| Net Margin | 7.5% | 5.8% | · | 4.4% | 5.9% | 5.1% | · | 6.6% | 7.0% | 7.8% | · | 7.9% | 6.0% | 4.0% | · | 3.6% | |
| Pretax Margin | 12.2% | 10.0% | · | 9.0% | 10.9% | 8.9% | · | 11.4% | 11.7% | 12.1% | · | 12.1% | 9.8% | 7.5% | · | 7.0% | |
| EBITDA Margin | 16.3% | 19.3% | · | 14.8% | 15.9% | 19.1% | · | 16.4% | 15.9% | 21.9% | · | 15.9% | 13.5% | 17.1% | · | 10.6% | |
| ROA | 1.5% | 1.1% | · | 0.86% | 1.1% | 0.94% | · | 1.2% | 1.3% | 1.4% | · | 1.5% | 1.1% | 0.68% | · | 0.61% | |
| ROE | -46.8% | -38.6% | · | -162.4% | 151.4% | 49.5% | · | 27.1% | 27.0% | 27.4% | · | 28.5% | 22.0% | 13.8% | · | 12.5% | |
| ROIC | -59.7% | -51.4% | · | -68.8% | -108.5% | -133.3% | · | 109.5% | 64.6% | 43.0% | · | 33.8% | 33.2% | 30.0% | · | 46.5% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.4 | · | 1.4 | 1.4 | 1.3 | · | 1.4 | 1.2 | 1.4 | · | 1.2 | 1.2 | 1.2 | · | 1.3 | |
| Quick Ratio | 1.1 | 1.1 | · | 1.0 | 1.1 | 1.0 | · | 1.1 | 0.9 | 1.1 | · | 1.0 | 1.0 | 0.9 | · | 1.0 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 1.4 | 1.4 | · | 1.5 | 1.4 | 1.3 | · | 1.5 | 1.5 | 1.3 | · | 1.5 | 1.5 | 1.4 | · | 1.4 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-11.96 | $-10.92 | · | $-8.06 | $-4.98 | $-3.46 | · | $4.68 | $7.44 | $10.31 | · | $13.13 | $11.15 | $9.11 | · | $5.91 | |
| Revenue / Share | $53.77 | $49.59 | · | $46.36 | $43.68 | $39.66 | · | $38.04 | $35.83 | $33.91 | · | $33.19 | $32.12 | $31.06 | · | $31.62 | |
| Cash Flow / Share | · | $4.66 | · | · | · | $2.21 | · | · | · | $-1.49 | · | · | · | $5.00 | · | · | |
| Cash / Share | $10.46 | $9.31 | · | $9.95 | $9.55 | $5.68 | · | $12.96 | $4.90 | $3.84 | · | $4.92 | $3.59 | $3.50 | · | $4.08 | |
| EPS (TTM) | $12.15 | $10.71 | · | $9.70 | $10.16 | $10.08 | · | $9.29 | $9.41 | $8.82 | · | $6.59 | $5.10 | $5.49 | · | $6.85 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $14.01B | $13.84B | · | $13.32B | $13.16B | $12.97B | · | $12.67B | $12.52B | $12.34B | · | $11.91B | $11.74B | $11.67B | · | $11.64B | |
| Net Income TTM | $847M | $781M | · | $772M | $836M | $860M | · | $828M | $860M | $816M | · | $609M | $468M | $514M | · | $680M | |
| Market Cap | $14.23B | $10.63B | · | $9.43B | $10.57B | $11.82B | · | $13.54B | $11.79B | $12.40B | · | $8.64B | $9.17B | $7.35B | · | $7.46B | |
| P/E | 18.3 | 14.4 | · | 13.7 | 14.0 | 15.2 | · | 17.6 | 14.7 | 15.7 | · | 14.3 | 19.7 | 14.8 | · | 12.1 | |
| P/S | 1.0 | 0.8 | · | 0.7 | 0.8 | 0.9 | · | 1.1 | 0.9 | 1.0 | · | 0.7 | 0.8 | 0.6 | · | 0.6 | |
| P/B | -18.6 | -14.1 | · | -16.5 | -28.6 | -44.3 | · | 35.0 | 18.6 | 13.4 | · | 7.2 | 9.0 | 8.9 | · | 14.0 | |
| P / Cash Flow | · | 33.1 | · | · | · | 65.7 | · | · | · | -92.0 | · | · | · | 15.9 | · | · | |
| Earnings Yield | 5.5% | 7.0% | · | 7.3% | 7.1% | 6.6% | · | 5.7% | 6.8% | 6.4% | · | 7.0% | 5.1% | 6.8% | · | 8.3% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B |
| Operating Margin % | 15.0% | 16.3% | 13.2% | 11.5% | 15.5% |
| Net Income | $747M | $936M | $692M | $560M | $978M |
| Diluted EPS | $9.84 | $10.73 | $7.42 | $5.85 | $8.90 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.3 | 1.2 | 1.2 | 1.3 |
| Quick Ratio | 1.0 | 1.0 | 0.9 | 0.9 | 1.0 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $1.31B | $1.47B | $1.49B | $961M | $1.29B |
Institutional owners (13F) 692 filers · $13.6B total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
692
Value held
$13.6B
New positions
126
Exited positions
61
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 126 (-14 vs prior Q) | 61 (-2 vs prior Q) | 195 (+23 vs prior Q) | 226 (+12 vs prior Q) | -1.1M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Berkshire Hathaway Inc | $6,425,268,898 | 28,880,209 | 47.23% | Shares |
| BlackRock, Inc. | $547,520,494 | 2,460,987 | 4.02% | Shares |
| VANGUARD GROUP INC | $471,976,159 | 4,154,354 | 3.47% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $467,525,034 | 2,101,425 | 3.44% | Shares |
| MORGAN STANLEY | $356,348,822 | 1,601,710 | 2.62% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $306,558,307 | 1,377,914 | 2.25% | Shares |
| STATE STREET CORP | $294,345,267 | 1,323,019 | 2.16% | Shares |
| Invesco Ltd. | $269,627,293 | 1,211,917 | 1.98% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $253,130,449 | 1,137,814 | 1.86% | Shares |
| NEUBERGER BERMAN GROUP LLC | $205,758,498 | 925,579 | 1.51% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $197,802,963 | 889,082 | 1.45% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $189,562,167 | 853,602 | 1.39% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $163,166,832 | 733,400 | 1.20% | Call option |
| Gates Capital Management, Inc. | $153,096,497 | 688,136 | 1.13% | Shares |
| BANK OF AMERICA CORP /DE/ | $145,056,737 | 651,999 | 1.07% | Shares |
| D. E. Shaw & Co., Inc. | $142,571,191 | 640,827 | 1.05% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $128,131,338 | 587,758 | 0.94% | Shares |
| GOLDMAN SACHS GROUP INC | $103,093,004 | 463,381 | 0.76% | Shares |
| Bank of New York Mellon Corp | $101,127,189 | 454,545 | 0.74% | Shares |
| NORDEA INVESTMENT MANAGEMENT AB | $87,427,043 | 395,687 | 0.64% | Shares |
| NORTHERN TRUST CORP | $84,995,593 | 382,037 | 0.62% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $81,331,791 | 365,569 | 0.60% | Shares |
| NORGES BANK | $76,627,007 | 344,422 | 0.56% | Shares |
| UBS Group AG | $67,900,673 | 305,199 | 0.50% | Shares |
| JANE STREET GROUP, LLC | $62,548,028 | 281,140 | 0.46% | Shares |
| JANE STREET GROUP, LLC | $53,573,184 | 240,800 | 0.39% | Call option |
| Holocene Advisors, LP | $52,875,709 | 237,665 | 0.39% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $48,100,176 | 216,200 | 0.35% | Put option |
| ROYAL BANK OF CANADA | $47,787,000 | 214,787 | 0.35% | Shares |
| DEUTSCHE BANK AG\ | $46,356,378 | 208,362 | 0.34% | Shares |
| Quantinno Capital Management LP | $45,366,106 | 203,910 | 0.33% | Shares |
| JPMORGAN CHASE & CO | $44,467,785 | 200,781 | 0.33% | Shares |
| CITADEL ADVISORS LLC | $44,465,298 | 199,862 | 0.33% | Shares |
| CITADEL ADVISORS LLC | $44,184,528 | 198,600 | 0.32% | Call option |
| BARCLAYS PLC | $43,410,740 | 195,122 | 0.32% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $40,134,502 | 180,396 | 0.30% | Shares |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $37,089,700 | 241,328 | 0.27% | Shares |
| Gotham Asset Management, LLC | $36,393,278 | 163,580 | 0.27% | Shares |
| JANE STREET GROUP, LLC | $35,774,784 | 160,800 | 0.26% | Put option |
| Doma Perpetual Capital Management LLC | $35,522,937 | 159,668 | 0.26% | Shares |
| FIRST TRUST ADVISORS LP | $34,161,205 | 153,548 | 0.25% | Shares |
| TODD ASSET MANAGEMENT LLC | $32,697,663 | 146,969 | 0.24% | Shares |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $32,011,312 | 143,884 | 0.24% | Shares |
| Allianz Asset Management GmbH | $30,236,367 | 135,906 | 0.22% | Shares |
| Toroso Investments, LLC | $29,297,520 | 257,878 | 0.22% | Shares |
| CANADA PENSION PLAN INVESTMENT BOARD | $26,480,460 | 119,024 | 0.19% | Shares |
| VICTORY CAPITAL MANAGEMENT INC | $26,377,896 | 118,563 | 0.19% | Shares |
| Amundi | $25,967,198 | 116,717 | 0.19% | Shares |
| FMR LLC | $25,475,535 | 114,507 | 0.19% | Shares |
| Davidson Kempner Capital Management LP | $25,162,043 | 113,098 | 0.18% | Shares |
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Warren E. Buffett, Berkshire Hathaway Inc., National Indemnity Company, GEICO Corporation, Government Employees Insurance Company, Berkshire Hathaway Consolidated Pension Plan Master Trust, BNSF Master Retirement Trust, Scott Fetzer Company Collective Investment Trust, R. Ted Weschler ×13 filings | Feb. 13, 2025 | 45.00% | Amendment | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 59 insiders · 31 officers · 25 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Javier Rodriguez | Chief Executive Officer | June 16, 2026 S | 840,408 | 0 | 2 | $-14,532,097 |
| Dennis Kogod | Pres, HCP & CEO, DVA Int. | May 17, 2016 S | 18,766 | 0 | 0 | $0 |
| Joel Ackerman | CFO and Treasurer | May 7, 2026 S | 132,434 | 0 | 1 | $-9,887,579 |
| Luis Borgen | Chief Financial Officer | March 22, 2012 M | 18,517 | 0 | 0 | $0 |
| Richard K Whitney | Chief Financial Officer | March 31, 2010 A | 33,604 | 0 | 0 | $0 |
| Mark G Harrison | Chief Financial Officer | March 14, 2007 A | 31,250 | 0 | 0 | $0 |
| Gary Beil | Acting Chief Financial Officer | July 1, 2006 A | 10,000 | 0 | 0 | $0 |
| David Paul Maughan | Chief Operating Officer, DKC | Sept. 22, 2026 F | 86,604 | 0 | 2 | $-4,089,696 |
| Michael David Staffieri | Chief Operating Officer, DKC | Aug. 16, 2024 S | 209,365 | 0 | 0 | $0 |
| Joseph C Mello | COO, HCP | Dec. 24, 2016 A | 4,688 | 0 | 0 | $0 |
| Kathleen Alyce Waters | Chief Legal & Pub. Affairs Off | June 15, 2026 S | 109,194 | 0 | 2 | $-3,210,360 |
| James O Hearty | Chief Compliance Officer | May 14, 2026 M | 22,389 | 0 | 2 | $-3,291,616 |
| Christopher Michael Berry | Chief Accounting Officer | March 15, 2026 A | 19,640 | 0 | 0 | $0 |
| John D Winstel | Chief Accounting Officer | March 15, 2023 F | 15,676 | 0 | 0 | $0 |
| Leanne M Zumwalt | Group VP, Government Affairs | Sept. 18, 2020 M | 24,590 | 0 | 0 | $0 |
| Kent J Thiry | Executive Chairman | June 1, 2020 F | 110,462 | 0 | 0 | $0 |
| James K Hilger | Chief Accounting Officer | June 2, 2019 F | 33,125 | 0 | 0 | $0 |
| Jeanine Marie Jiganti | Chief Compliance Officer | June 13, 2017 M | 3,514 | 0 | 0 | $0 |
| Kim M Rivera | Chief Legal Officer | Sept. 22, 2015 M | 7,438 | 0 | 0 | $0 |
| Robert J Margolis | Co-Chairman of the Board | June 4, 2015 S | 2,322,928 | 0 | 0 | $0 |
| Allen Nissenson | Chief Medical Officer | Feb. 13, 2014 M | 8,990 | 0 | 0 | $0 |
| Garry E Menzel | Senior Vice President, Finance | Sept. 9, 2013 A | · | 0 | 0 | $0 |
| David T Shapiro | Chief Special Counsel | Aug. 2, 2013 G | 2,315 | 0 | 0 | $0 |
| Thomas O Usilton | Senior Vice President | Feb. 29, 2012 M | 17,491 | 0 | 0 | $0 |
| Georgina Randolph | Senior Vice President | June 17, 2009 M | 5,547 | 0 | 0 | $0 |
| Joseph Schohl | VP, Gen. Counsel & Secretary | Feb. 13, 2009 M | 2,084 | 0 | 0 | $0 |
| Christopher J Riopelle | Chief Compliance Officer | Aug. 11, 2008 M | 2,500 | 0 | 0 | $0 |
| Mary Kowenhoven | Vice President - Strategy | March 5, 2008 A | · | 0 | 0 | $0 |
| Patricia Jones | Chief People Officer | July 16, 2007 A | 6,250 | 0 | 0 | $0 |
| Charles J Mcallister | Chief Medical Officer | May 8, 2007 M | 999 | 0 | 0 | $0 |
| Thomas L Kelly | Executive Vice President | Nov. 4, 2005 M | 42,000 | 0 | 0 | $0 |
| Dennis W Pullin | Director | Aug. 15, 2026 A | 2,949 | 0 | 0 | $0 |
| Gregory J. Moore | Director | Aug. 15, 2026 A | 8,091 | 0 | 0 | $0 |
| Jason M. Hollar | Director | Aug. 15, 2026 A | 6,883 | 0 | 0 | $0 |
| Patricia M Arway | Director | Aug. 15, 2026 A | 27,223 | 0 | 0 | $0 |
| Adam H Schechter | Director | Aug. 15, 2026 A | 5,970 | 0 | 0 | $0 |
| Wendy Lee Schoppert | Director | Aug. 15, 2026 A | 278 | 0 | 0 | $0 |
| Phyllis R Yale | Director | Aug. 15, 2026 A | 9,803 | 0 | 0 | $0 |
| Barbara J Desoer | Director | Aug. 15, 2026 A | 278 | 0 | 0 | $0 |
| Charles Berg | Director | May 15, 2025 A | 19,982 | 0 | 0 | $0 |
| John M Nehra | Director | May 15, 2024 A | 363 | 0 | 0 | $0 |
| Paul J Diaz | Director | May 15, 2023 A | 16,069 | 0 | 0 | $0 |
| Paula A Price | Director | May 15, 2022 A | 1,395 | 0 | 0 | $0 |
| Shawn M Guertin | Director | May 15, 2021 A | 1,105 | 0 | 0 | $0 |
| Pascal Desroches | Director | Nov. 15, 2020 A | 8,030 | 0 | 0 | $0 |
| William L Roper | Director | June 11, 2020 A | 16,234 | 0 | 0 | $0 |
| Peter T Grauer | Director | June 11, 2020 A | 76,204 | 0 | 0 | $0 |
| Carol Anthony Davidson | Director | Dec. 31, 2017 A | 10,764 | 0 | 0 | $0 |
| Willard Woodson Brittain JR | Director | June 11, 2012 A | 7,195 | 0 | 0 | $0 |
| Richard C Vaughan | Director | May 13, 2010 A | 6,092 | 0 | 0 | $0 |
| Nancy Ann Deparle | Director | June 30, 2008 A | 3,256 | 0 | 0 | $0 |
| Raymond C Larkin JR | Director | March 31, 2007 A | 8,684 | 0 | 0 | $0 |
| Michele J Hooper | Director | May 13, 2005 A | 680 | 0 | 0 | $0 |
| R. Ted Weschler | · | Sept. 17, 2020 S | 1,991,806 | 0 | 0 | $0 |
| Roger Valine | · | June 30, 2017 A | 306 | 0 | 0 | $0 |
| Laura Mildenberger | · | Dec. 17, 2015 M | 8,447 | 0 | 0 | $0 |
| Richard B Fontaine | · | May 16, 2007 G | 10,000 | 0 | 0 | $0 |
| Lori Richardson Pelliccioni | · | Feb. 25, 2005 M | 3,000 | 0 | 0 | $0 |
| Patrick A Broderick | · | May 5, 2004 M | 0 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 97 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| OMAH · Tidal Trust III | 5.19% | 213,947 NS | July 31, 2026 | N-PORT |
| STNC · Hennessy Funds Trust | 3.36% | 13,006 NS | July 31, 2026 | N-PORT |
| AZTD · Tidal Trust I | 3.06% | 4,824 NS | July 31, 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 2.44% | 106,663 NS | July 31, 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.59% | 78,593 SH | Oct. 2, 2026 | Daily |
| AMOM · Exchange Listed Funds Trust | 1.41% | 1,399 NS | July 31, 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 1.19% | 760 NS | July 31, 2026 | N-PORT |
| IHF · iShares Trust | 0.85% | 61,700 SH | Sept. 11, 2026 | Daily |
| JMID · Janus Detroit Street Trust | 0.46% | 456 NS | July 31, 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0.46% | 8,917 NS | July 31, 2026 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0.34% | 4,688 NS | July 31, 2026 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0.34% | 6,488 NS | July 31, 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0.31% | 9,914 SH | Aug. 19, 2026 | Daily |
| ROSC · Lattice Strategies Trust | 0.27% | 691 NS | July 31, 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0.24% | 22,513 SH | Oct. 2, 2026 | Daily |
| BKMC · BNY Mellon ETF Trust | 0.22% | 5,948 NS | July 31, 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.20% | 126,925 NS | July 31, 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0.20% | 1,066,571 SH | Oct. 2, 2026 | Daily |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0.18% | 15,260 NS | July 31, 2026 | N-PORT |
| FNK · First Trust Exchange-Traded AlphaDE… | 0.15% | 1,456 NS | July 31, 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0.15% | 467,367 SH | Aug. 19, 2026 | Daily |
| FHLC · FIDELITY COVINGTON TRUST | 0.12% | 15,871 NS | July 31, 2026 | N-PORT |
| ISCG · iShares Trust | 0.12% | 6,102 SH | Sept. 11, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | 0.11% | 100,394 SH | Aug. 19, 2026 | Daily |
| ESML · iShares Trust | 0.10% | 16,178 SH | Sept. 11, 2026 | Daily |
| IYH · iShares Trust | 0.09% | 18,805 SH | Sept. 11, 2026 | Daily |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.09% | 4,169 SH | Oct. 2, 2026 | Daily |
| VB · VANGUARD INDEX FUNDS | 0.09% | 736,199 SH | Aug. 19, 2026 | Daily |
| CURE · Direxion Shares ETF Trust | 0.09% | 632 NS | July 31, 2026 | N-PORT |
| SMMD · iShares Trust | 0.08% | 17,274 SH | Sept. 11, 2026 | Daily |
| FNX · First Trust Exchange-Traded AlphaDE… | 0.08% | 4,629 NS | July 31, 2026 | N-PORT |
| TILT · FlexShares Trust | 0.08% | 7,288 NS | July 31, 2026 | N-PORT |
| IXJ · iShares Trust | 0.07% | 16,934 SH | Sept. 11, 2026 | Daily |
| RWL · Invesco Exchange-Traded Fund Trust … | 0.07% | 38,130 SH | Oct. 2, 2026 | Daily |
| DFAC · Dimensional ETF Trust | 0.06% | 121,442 NS | July 31, 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0.06% | 3,250 SH | Oct. 2, 2026 | Daily |
| DUHP · Dimensional ETF Trust | 0.06% | 29,605 NS | July 31, 2026 | N-PORT |
| WSML · iShares Trust | 0.05% | 2,005 SH | Sept. 10, 2026 | Daily |
| IWS · iShares Trust | 0.05% | 45,297 SH | Sept. 11, 2026 | Daily |
| FAB · First Trust Exchange-Traded AlphaDE… | 0.05% | 322 NS | July 31, 2026 | N-PORT |
| IWR · iShares Trust | 0.04% | 131,978 SH | Sept. 11, 2026 | Daily |
| DCOR · Dimensional ETF Trust | 0.04% | 5,974 NS | July 31, 2026 | N-PORT |
| CATH · Global X Funds | 0.04% | 1,967 NS | July 31, 2026 | N-PORT |
| XOEF · iShares Trust | 0.04% | 43 SH | Sept. 10, 2026 | Daily |
| PRF · Invesco Exchange-Traded Fund Trust | 0.03% | 15,586 SH | Oct. 2, 2026 | Daily |
| SPMO · Invesco Exchange-Traded Fund Trust … | 0.03% | 34,460 SH | Oct. 2, 2026 | Daily |
| DFAU · Dimensional ETF Trust | 0.03% | 13,203 NS | July 31, 2026 | N-PORT |
| CHRI · Global X Funds | 0.02% | 8 NS | July 31, 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.02% | 2,124 NS | July 31, 2026 | N-PORT |
| EGLE · Global X Funds | 0.02% | 2 NS | July 31, 2026 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0.02% | 7,420 SH | Aug. 19, 2026 | Daily |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.02% | 18,428 SH | Aug. 19, 2026 | Daily |
| IVE · iShares Trust | 0.02% | 53,283 SH | Sept. 11, 2026 | Daily |
| IUSV · iShares Trust | 0.02% | 27,948 SH | Sept. 11, 2026 | Daily |
| NEAR · iShares U.S. ETF Trust | 0.02% | 949,000 SH | Sept. 9, 2026 | Daily |
| DSI · iShares Trust | 0.02% | 4,810 SH | Sept. 11, 2026 | Daily |
| IWD · iShares Trust | 0.01% | 67,699 SH | Sept. 11, 2026 | Daily |
| XRMI · Global X Funds | 0.01% | 30 NS | July 31, 2026 | N-PORT |
| XYLD · Global X Funds | 0.01% | 1,746 NS | July 31, 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0.01% | 1,706 NS | July 31, 2026 | N-PORT |
| DYNF · BlackRock ETF Trust | 0.01% | 27,844 SH | Sept. 11, 2026 | Daily |
| XYLG · Global X Funds | 0.01% | 32 NS | July 31, 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0.01% | 121 NS | July 31, 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.01% | 9,492 NS | July 31, 2026 | N-PORT |
| QDPL · Pacer Funds Trust | 0.01% | 766 NS | July 31, 2026 | N-PORT |
| TOPC · iShares Trust | 0.01% | 19 SH | Sept. 10, 2026 | Daily |
| XVV · iShares Trust | 0.01% | 377 SH | Sept. 10, 2026 | Daily |
| VOO · VANGUARD INDEX FUNDS | 0.01% | 832,243 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.01% | 1,019,458 SH | Aug. 19, 2026 | Daily |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.01% | 28,136 SH | Aug. 19, 2026 | Daily |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.01% | 5,315 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.01% | 2,714 SH | Aug. 19, 2026 | Daily |
| ESGV · VANGUARD WORLD FUND | 0.01% | 7,283 SH | Aug. 19, 2026 | Daily |
| XTR · Global X Funds | 0.01% | 2 NS | July 31, 2026 | N-PORT |
| HCMT · Direxion Shares ETF Trust | 0.01% | 225 NS | July 31, 2026 | N-PORT |
| IWP · iShares Trust | 0.01% | 9,703 SH | Sept. 11, 2026 | Daily |
| PBP · Invesco Exchange-Traded Fund Trust | 0.01% | 203 SH | Sept. 30, 2026 | Daily |
| SPXL · Direxion Shares ETF Trust | 0.01% | 2,512 NS | July 31, 2026 | N-PORT |
| IVV · iShares Trust | 0.01% | 404,382 SH | Sept. 11, 2026 | Daily |
| IWB · iShares Trust | 0.01% | 22,249 SH | Sept. 11, 2026 | Daily |
| IYY · iShares Trust | 0.01% | 1,374 SH | Sept. 10, 2026 | Daily |
| IWV · iShares Trust | 0.01% | 8,841 SH | Sept. 10, 2026 | Daily |
| ITOT · iShares Trust | 0.01% | 41,624 SH | Sept. 11, 2026 | Daily |
| PHDG · Invesco Actively Managed Exchange-T… | 0.01% | 24 SH | Sept. 30, 2026 | Daily |
| XCLR · Global X Funds | 0.01% | 1 NS | July 31, 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0.01% | 1,542 SH | Oct. 2, 2026 | Daily |
| IWF · iShares Trust | 0.00% | 6,443 SH | Sept. 2, 2026 | Daily |
| GTO · Invesco Actively Managed Exchange-T… | 0.00% | 7,000 | Sept. 30, 2026 | Daily |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0.00% | 2,838 SH | Aug. 19, 2026 | Daily |
| VGHY · VANGUARD FIXED INCOME SECURITIES FU… | · | · | July 15, 2026 | Daily |
| VCRB · VANGUARD MALVERN FUNDS | · | · | July 15, 2026 | Daily |
| VPLS · VANGUARD MALVERN FUNDS | · | · | July 15, 2026 | Daily |
| VGMS · VANGUARD MALVERN FUNDS | · | · | July 15, 2026 | Daily |
| ISCB · iShares Trust | · | 1,571 SH | Sept. 11, 2026 | Daily |
| ISCV · iShares Trust | · | 3,661 SH | Sept. 11, 2026 | Daily |
| SMLF · iShares Trust | · | 5,973 SH | Sept. 11, 2026 | Daily |
| SMMV · iShares Trust | · | 1,837 SH | Sept. 1, 2026 | Daily |
DVA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 13 analysts
BUY
Median target
$220.00
+23.1%
1 7.7%
Strong Buy
6 46.2%
Buy
5 38.5%
Hold
1 7.7%
Sell
0 0.0%
Strong Sell
12-Month Price Target
7 analysts · 2026-10-04Mean target $219.86 +23.0%
Now
Current price $178.69
Low$165.00
Mean$219.86
High$270.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| DVA | $7.79B | 11.5 | 6.5% | 5.5% | -281.8% | · |
| DGX | $19.09B | 19.8 | 11.8% | 9.0% | 14.2% | · |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| GH | $13.34B | -30.8 | 32.9% | -42.4% | 205.7% | · |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| BTSG | $7.20B | 43.0 | 28.2% | 1.5% | 10.8% | 11.8% |
| HNGE | $0 | -6.0 | 50.6% | -89.9% | -299.8% | 79.7% |
| HIMS | · | 63.7 | 59.0% | 5.5% | 23.3% | 73.8% |
| CHE | · | 23.3 | 4.1% | 10.5% | 24.4% | · |
| RDNT | $5.28B | -285.4 | 11.5% | -0.91% | -1.9% | · |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | · |
Trading Signals Recent buy/sell signals with entry price and risk/reward ratio
BLUECHIP_DIP
Stopped out
risk 1
reward 2.08
entry
$179.50
R:R 2.08
BLUECHIP_DIP
Expired
risk 1
reward 2.08
entry
$176.69
R:R 2.08
No open signal right now — no card is filled, and that's honest.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 4, 2026